technetium Tc 99m arcitumomab

an anti-CEA Fab' labeled with technetium
Also Known As:
CEA scan; Tc-99m arcitumomab
Networked: 15 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Drug Context: Research Results


1. Hasni, Sofia: 1 article (07/2003)
2. Belgraier, Arnold: 1 article (07/2003)
3. Ghesani, Munir: 1 article (07/2003)
4. Rodado Marina, S: 1 article (09/2002)
5. Poblete García, V M: 1 article (09/2002)
6. García Vicente, A: 1 article (09/2002)
7. Soriano Castrejón, A: 1 article (09/2002)
8. González, R: 1 article (09/2002)
9. Bartlett, D L: 1 article (12/2001)
10. Bacharach, S L: 1 article (12/2001)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
01/01/1999 - "In a surgical decision-making analysis comparing CT, RIS (IMMU-4 99mTc-Fab'; CEA-Scan), and CT plus RIS in patients with recurrent or metastatic colorectal cancer, CT plus RIS improved correct prediction of resectability by 40% and correct prediction of unresectability by 100% compared with CT alone. "
09/01/2002 - "48 studies underwent to 45 patients (25 men and 20 women) with an average age of 64, diagnosed and treated of colorectal cancer, 5 hours after the intravenous administration of 1.25 mg of arcitumomab (CEA-scan) labelled with 945 MBq of 99mTc. "
03/01/2000 - "After reading this article, the nuclear medicine technologist will be able to: (a) describe the role of Arcitumomab in evaluating and managing patients with recurrent colorectal carcinoma metastasizing to the liver; (b) discuss the clinical use of CEA-Scan (Immunomedics, Inc., Morris Plains, NJ) and its overall imaging performance characteristics and sensitivity related to specific anatomical sites compared to conventional diagnostic modalities; (c) describe radiopharmaceutical preparation and quality control; (d) identify the pertinent patient history before starting the test; and (e) explain the imaging procedure, processing and display of data to optimize study interpretation."
12/01/1999 - "CEA-Scan (a 99mTclabeled Fab' fragment of a mouse mAb directed against CEA) has several advantageous properties, and has been approved for use in colorectal cancer SPECT imaging in North America and Europe, and is also under investigation in Japan. "
04/11/1997 - "22 patients, operated on for colorectal carcinoma and suspected of having a recurrence, underwent scintigraphy with CEA-scan and whole-body single-photon emission computed tomography (SPECT). "
2. Neoplasms (Cancer)
3. Rectal Neoplasms (Rectal Cancer)
4. Colonic Neoplasms (Colon Cancer)
5. Thyroid Neoplasms (Thyroid Cancer)

Related Drugs and Biologics

1. Carcinoembryonic Antigen
2. Immunoglobulin Fab Fragments
3. Deoxyglucose (2 Deoxy D glucose)
4. Antigens
5. Antibodies
6. monoclonal antibody IMMU 4
7. Indium 111In-satumomab pendetide

Related Therapies and Procedures

1. Laparotomy